Works matching IS 0033-3158 AND VI 239 AND IP 7 AND DT 2022


Results: 29
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization.

    Published in:
    Psychopharmacology, 2022, v. 239, n. 7, p. 2215, doi. 10.1007/s00213-022-06108-6
    By:
    • Nirogi, Ramakrishna;
    • Abraham, Renny;
    • Jayarajan, Pradeep;
    • Goura, Venkatesh;
    • Kallepalli, Rajesh;
    • Medapati, Rajesh babu;
    • Tadiparthi, Jayaprakash;
    • Goyal, Vinod kumar;
    • Pandey, Santosh kumar;
    • Subramanian, Ramkumar;
    • Petlu, Surendra;
    • Thentu, Jagadeesh Babu;
    • Palacharla, Veera Raghava Chowdary;
    • Gagginapally, Shankar Reddy;
    • Mohammed, Abdul Rasheed;
    • Jasti, Venkat
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23

    Striatal dopamine synthesis capacity and its association with negative symptoms upon resolution of positive symptoms in first-episode schizophrenia and delusional disorder.

    Published in:
    Psychopharmacology, 2022, v. 239, n. 7, p. 2133, doi. 10.1007/s00213-022-06088-7
    By:
    • Wong, Stephanie M. Y.;
    • Suen, Y. N.;
    • Wong, Charlotte W. C.;
    • Chan, Sherry K. W.;
    • Hui, Christy L. M.;
    • Chang, W. C.;
    • Lee, Edwin H. M.;
    • Cheng, Calvin P. W.;
    • Ho, Garrett C. L.;
    • Lo, Gladys Goh;
    • Leung, Eric Y. L.;
    • Yeung, Paul K. M. Au;
    • Chen, Sirong;
    • Honer, William G.;
    • Mak, Henry K. F.;
    • Sham, P. C.;
    • McKenna, Peter J.;
    • Pomarol-Clotet, Edith;
    • Veronese, Mattia;
    • Howes, Oliver D.
    Publication type:
    Article
    24

    Thank you to referees!

    Published in:
    Psychopharmacology, 2022, v. 239, n. 7, p. 2363, doi. 10.1007/s00213-022-06085-w
    Publication type:
    Article
    25
    26
    27
    28
    29